CASC8

CASC8 is a pioneering biotech company developing a first-in-class regenerative cell therapy that directly restores damaged heart muscle —addressing the root cause of heart failure rather than managing symptoms. With strong preclinical validation and a scalable, off-the-shelf platform, CASC8 is posit... Read more